However, this commercial success has not been accompanied by safe, prudent, and cost-effective use 5. Reports of pregabalin’s addictive potential began to appear immediately after the drug’s market launch in 2005 6, the first cases of pregabalin abuse in Europe were recorded in 2008 7, and the first pregabalin use disorders were diagnosed in 2010 8. Pregabalin and gabapentin are medications that have some differences in their mechanism of action. Both act on voltage-dependent calcium channels in presynaptic neurons, reducing the release of excitatory neurotransmitters such as glutamate, thereby decreasing the transmission of pain signals in the central nervous system (46). However, pregabalin has a higher affinity for these channels, resulting in more potent inhibition of neurotransmitter release.

• Researchers from Oxford University have also noted the similarity between the current abuse of gabapentinoids and the abuse of opioids in the 1990s, emphasising the importance of a more responsible approach to this problem in order to avoid the mistakes made in the 1990s with opioids 212.
• Similar lesions were not observed in lifetime carcinogenicity studies in two strains of mice or in monkeys treated for 1 year.
• As Europe has a high prevalence of several chronic diseases, such as epilepsy and neuropathy, the demand for pregabalin in the market is expected to be strong in the region.
• Given the commitment of doctors to prescribing pregabalin and the lack of warnings about the negative consequences, it is imperative to educate healthcare professionals about the risks of such prescriptions.

6 Increased Risk of Adverse Reactions with Abrupt or Rapid Discontinuation

As with all antiepileptic drugs (AEDs), withdraw LYRICA gradually to minimize the potential of increased seizure frequency lyrica over the counter in patients with seizure disorders. There have been postmarketing reports of angioedema in patients during initial and chronic treatment with LYRICA. Specific symptoms included swelling of the face, mouth (tongue, lips, and gums), and neck (throat and larynx). There were reports of life-threatening angioedema with respiratory compromise requiring emergency treatment.